Mild AD: Little-to-no benefit found in this group.
Moderate-severe AD: For every 6–7 people treated, 1 person benefits in a small, but consistent, meaningful way, such as:
Thinking a little clearer and managing daily activities better
Can sometimes lessen agitation, aggression, or irritability
When memantine is taken together with another medicine (donepezil), people were able to stay at home longer before needing full-time care
Combined treatment, Memantine + cholinesterase inhibitors, may yield slightly better results than either alone.
Side effects are few and rare (e.g., dizziness, headache), so most people tolerate memantine well.
Some reviews suggest limited real-life impact despite statistical gains.
Memantine can help slow memory loss, behavior changes, and loss of daily skills somewhat—but mostly for people in the moderate-to-severe stages of Alzheimer’s. It doesn’t make a big difference, and it doesn’t help much when the disease is mild. Often, doctors use it alongside other medications for a bit more benefit. The good news is that it’s usually easy to take and rarely causes serious side effects.